Advances in harnessing the immune system for therapeutic development have resulted in a robust pipeline of immuno-oncology therapies and novel combinations. A successful program requires appropriate models and tools for preclinical evaluation and effective strategies for translation. Our expert speakers will discuss choosing the right preclinical m
08-09 August 2023